Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALPHA2PREVENT delirium prevention after open heart surgery
2023-510212-39-00Phase 4Authorised
- Sponsor
- Oslo University Hospital
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in delirium comparing Clonidine arm, Dexmedetomidine arm and Placebo arm (3 arms). Primary endpoint: Cumulative incidence of postoperative delirium. Planned start Sep 2024; status: authorised.
02
Drugs
clonidinedexmedetomidine
03
Conditions
delirium
Beyond the preview
Go deeper on 2023-510212-39-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-510212-39-00.